Background: The objective of this study is to describe incidence and shifts of serotype and clonal distribution of invasive Streptococcus pneumoniae strains in four different age groups (65 years) during a period of intermediate PCV13 vaccination coverage (2011-2016) in Catalonia, Spain. Methods: We included all pneumococcal strains systematically sent to the Catalan support laboratory for molecular surveillance of invasive pneumococcal disease (IPD) located at Hospital Sant Joan de Deu, Barcelona. Two study periods were considered: 2011-13, early PCV13 vaccination period (EVP) and 2014-2016, late vaccination period (LVP). Results A total of 2142 strains were included in the study. Five years after intermediate introduction of PCV13 in our ...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
The 10-valent pneumococcal conjugate vaccine (PCV10) became available in Portugal in mid-2009 and th...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
BACKGROUND:The objective of this study is to describe incidence and shifts of serotype and clonal di...
The goal of this study was to investigate the distribution of serotypes and clonal composition of St...
The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasiv...
Introduction of pneumococcal conjugate vaccines (PCVs) has shown a marked reduction in the disease c...
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccina-...
Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for ...
BACKGROUND: Streptococcus pneumoniae serotypes distribution in community-acquired pneumonia (CAP) re...
AbstractThe present study evaluated changes in the incidence of invasive pneumococcal disease (IPD) ...
SummaryObjectivesTo describe the distribution of vaccine and non-vaccine pneumococcal serotypes from...
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccinat...
<div><p>A prospective laboratory-based multicenter study that collected all adult invasive pneumococ...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
The 10-valent pneumococcal conjugate vaccine (PCV10) became available in Portugal in mid-2009 and th...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
BACKGROUND:The objective of this study is to describe incidence and shifts of serotype and clonal di...
The goal of this study was to investigate the distribution of serotypes and clonal composition of St...
The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasiv...
Introduction of pneumococcal conjugate vaccines (PCVs) has shown a marked reduction in the disease c...
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccina-...
Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for ...
BACKGROUND: Streptococcus pneumoniae serotypes distribution in community-acquired pneumonia (CAP) re...
AbstractThe present study evaluated changes in the incidence of invasive pneumococcal disease (IPD) ...
SummaryObjectivesTo describe the distribution of vaccine and non-vaccine pneumococcal serotypes from...
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccinat...
<div><p>A prospective laboratory-based multicenter study that collected all adult invasive pneumococ...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
The 10-valent pneumococcal conjugate vaccine (PCV10) became available in Portugal in mid-2009 and th...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...